Aminoguanidine Prevents Impaired Healing and Deficient Angiogenesis in Diabetic Rats

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Sharon M. Wahl, D A Hunt, Lalage M. Wakefield et al. · Proceedings of the National Academy of Sciences · 1987 · 1.3K citations · Full text

Life Sciences, Cell Biology, Immunology +17

Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Anita B. Roberts, Mario A. Anzano, Lalage M. Wakefield et al. · Proceedings of the National Academy of Sciences · 1985 · 1.1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

John A. Corbett, Ronald G. Tilton, Kathy Chang et al. · Diabetes · 1992 · 611 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Hans‐Peter Hammes, S. Martin, K. Federlin et al. · Proceedings of the National Academy of Sciences · 1991 · 529 citations

Medicine, Ophthalmology, Pharmacology +16

Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat

T. Soulis-Liparota, M. E. Cooper, D. Papazoglou et al. · Diabetes · 1991 · 399 citations

Medicine, Biochemistry, Pharmacology +13